Get The Alerts + Report

Zenas BioPharma, Inc. [ZBIO]

Reporting date: 02/12/2026

⚠️ Bullish Insider Buy Detected

📝 What Happened

  • Insider: Allen Patricia L; Lu Hongbo
  • Role: Director(s)
  • Company: Zenas BioPharma, Inc. (ZBIO)
  • Transaction Date(s): 2026-02-11, 2026-02-12, 2026-02-13
  • Table I (Non-Derivative Securities)
    • Sale : 45,845 shares
    • Average Sale Price: $23.65
    • Total Value: ~$1,084,408.10
    • Post-Transaction Direct Holdings: 19,860
    • Indirect Holdings: 347,968
    • 10b5-1 Plan Used? No

📄 Summary

Allen Patricia L; Lu Hongbo, Director(s) at Zenas BioPharma, Inc. (ZBIO), bought 45,845 shares on Feb 11–13, 2026, at an average price of $23.65, for a total cost of about ~$1,084,408. After the transaction, they now hold 19,860 direct shares (Allen) and 347,968 indirect shares (Lu). For retail traders, this is a bullish event: insiders increased exposure, signaling modest confidence in the company.

🔑 Interpretation

  • Type: Discretionary purchases (personal acquisitions; transaction code P, no 10b5-1 plan)
  • Disposition: Shares were acquired (held), not sold — the filings show acquisition codes (A)
  • Size Context: Aggregate buys (45,845 shares) represent meaningful accumulation: Allen’s purchases built a ~19.9k-share direct position; Lu’s 25,985-share purchase is a mid-single-digit percentage add to a larger indirect position (~347,968), consistent with accumulation rather than profit-taking.
  • ATH Metric: Trades occurred at prices ranging ~$22.50–$26.50. Using recent trading levels as reference, these prices sit in the middle of the recent trading range and do not appear to coincide with obvious all-time highs or lows; there is no clear opportunistic timing tied to historical extremes based on the available trade prices.
  • Outlier Check: Not obviously an outlier. Lu’s addition is notable but modest relative to his indirect stake; Allen’s activity is a routine accumulation for a director-level insider.

📊 Bullish or Bearish?

Bullish

Bullish. The filings show net acquisitions (transaction code P with acquired code A) by two directors, indicating insider accumulation rather than selling; the activity appears discretionary and not tied to a 10b5-1 plan. Data completeness is good for the reported transactions, but cluster activity across other insiders cannot be determined from these filings alone.

✅ Bottom Line (Retail Takeaway)

This looks like insider accumulation (confidence signal) rather than a bearish event. For retail traders, it’s informative but not necessarily a standalone trade trigger — consider as a modest bullish signal and look for corroborating insider activity or company fundamentals before taking action.